Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway
Renal cell carcinoma (RCC) is a hypermetabolic disease. Abnormal up-regulation of glycolytic signaling promotes tumor growth, and glycolytic metabolism is closely related to immunotherapy of renal cancer. The ...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Sichen Di, Min Gong, Jianmin Lv, Qiwei Yang, Ye Sun, Yijun Tian, Cheng Qian, Wenjin Chen, Wang Zhou, Keqin Dong, Xiaokai Shi, Yuning Wang, Hongru Wang, Jian Chu, Sishun Gan, Xiuwu Pan & hellip; Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma